UK
GSK to support manufacture of 60m Novavax COVID-19 vaccines
March 30, 2021Manufacturing and Production COVID-19, GSK, UK, Vaccine
GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …
Camallergy awarded £1.1m government funding for peanut allergy immunotherapy
March 9, 2021Manufacturing and Production Camallergy, UK, allergy
Camallergy, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded …
Seven mass vaccination sites open in England
January 11, 2021Sales and Marketing COVID-19, UK, Vaccine
Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …
New coronavirus strain identified in the UK
December 15, 2020Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines
A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …
MHRA warns patients with history of significant allergic reactions not to receive Pfizer/BioNTech COVID-19 vaccine
December 9, 2020Research and Development COVID-19, MHRA, UK, Vaccine
While the rolling out of Pfizer and BioNTech’s COVID-19 in the UK this week marked a historic moment in a …
UK launches COVID-19 vaccination drive with first dosings of Pfizer/BioNTech’s candidate
December 8, 2020Manufacturing and Production, Sales and Marketing COVID-19, UK, Vaccine
The first doses of Pfizer and BioNTech’s approved COVID-19 vaccine have been administered in the UK in a historic occasion …
NICE recommendation for AstraZeneca’s Calquence in chronic lymphocytic leukaemia populations
December 8, 2020Manufacturing and Production, Sales and Marketing AstraZeneca, NHS, NICE, UK, leukaemia
The National Institute for Health and Care Excellence (NICE) has recommended that AstraZeneca’s Calquence (acalabrutinib) be used on the NHS in …
Top Ten most popular articles on Pharmafile.com this week
December 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Dupixent, EMA, UK, Vaccine, top ten
As the year winds to a close, excitement is rising around the efficacy and availability of COVID-19 vaccines around the …
UK becomes first nation to approve Pfizer and BioNTech’s COVID-19 vaccine
December 2, 2020Research and Development, Sales and Marketing COVID-19, Pfizer, UK, Vaccine
The UK has become the first country worldwide to authorise Pfizer and BioNTech’s promising COVID-19 vaccine, the UK Government has …
UK secures another two million COVID-19 vaccine doses from Moderna
November 30, 2020Sales and Marketing COVID-19, Moderna, UK
The UK Government has expanded upon its previous negotiations with Moderna to secure an additional two million doses of its …
NICE recommends Lilly’s Emgality for chronic and episodic migraine
November 18, 2020Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK
Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …
UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy
November 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine
US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia
November 10, 2020Manufacturing and Production, Sales and Marketing AbbVie, NHS, NICE, UK, leukaemia, venetoclax
NICE has recommended venetoclax in combination with obinutuzumab under final draft guidance for the first-line treatment of untreated chronic lymphocytic …
Pharmafile.com’s weekly COVID-19 news round-up
November 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir
As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …
The November 2020 issue of Pharmafocus is available to read free online now!
October 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir
The latest monthly edition of Pharmafocus is available to read for free online now!
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
